Alyssa Wyant
General Counsel bei PRAXIS PRECISION MEDICINES, INC.
Profil
Alyssa Wyant is currently the Chief Regulatory & Quality Officer at Praxis Precision Medicines, Inc. She previously held positions as the Senior Director-International Regulatory Affairs at NPS Pharmaceuticals, Inc. from 2012 to 2015, Vice President-Global Regulatory Affairs at PTC Therapeutics, Inc. from 2015 to 2017, and Senior Vice President-Regulatory Affairs at Edge Therapeutics, Inc. She also served as the Senior Vice President-Regulatory Affairs at EryDel SpA from 2019 to 2020.
Ms. Wyant obtained her undergraduate degree from the University of Washington.
Aktive Positionen von Alyssa Wyant
| Unternehmen | Position | Beginn |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | General Counsel | 01.09.2020 |
Ehemalige bekannte Positionen von Alyssa Wyant
| Unternehmen | Position | Ende |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | General Counsel | 01.08.2020 |
| PTC THERAPEUTICS, INC. | General Counsel | 01.02.2017 |
| NPS PHARMACEUTICALS, INC. | General Counsel | 01.03.2015 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | General Counsel | - |
Ausbildung von Alyssa Wyant
| University of Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
